The Food and Drug Administration approved Abiomed Inc.’s (Nasdaq: ABMD)
Impella 2.5 heart pump sending the stock price soaring $12.22 to $73.65.
FDA approves Abiomed’s Impella 2.5
March 24, 2015 at 07:23 AM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|